Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$103.21
-0.6%
$103.46
$71.88
$107.53
$152.67B0.686.68 million shs389,929 shs
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
$18.28
-0.3%
$17.43
$13.11
$18.55
N/AN/A203,603 shs13,554 shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$516.99
-1.7%
$538.20
$413.82
$616.00
$185.25B1.641.67 million shs216,851 shs
Stryker Corporation stock logo
SYK
Stryker
$389.83
-1.3%
$384.57
$314.93
$406.19
$148.61B0.911.35 million shs82,588 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+0.81%-0.48%+4.60%+10.82%+34.61%
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
+0.27%-0.54%+3.79%+22.35%+4.74%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-0.39%-3.25%-0.67%+6.57%+18.28%
Stryker Corporation stock logo
SYK
Stryker
+0.67%+0.68%+2.46%+12.76%+16.99%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4.7253 of 5 stars
3.63.00.04.23.72.51.3
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.6964 of 5 stars
3.43.00.04.03.02.51.9
Stryker Corporation stock logo
SYK
Stryker
4.6431 of 5 stars
2.43.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
3.13
Buy$116.0911.84% Upside
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
0.00
N/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$592.5912.65% Upside
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$428.558.58% Upside

Current Analyst Ratings Breakdown

Latest SYK, CSQ, ISRG, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$470.00 ➝ $550.00
7/8/2025
Stryker Corporation stock logo
SYK
Stryker
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$390.00 ➝ $415.00
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$118.00
6/9/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell$515.00 ➝ $440.00
6/5/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
5/28/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$115.00
5/22/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$119.00 ➝ $125.00
5/22/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$590.00 ➝ $650.00
5/22/2025
Stryker Corporation stock logo
SYK
Stryker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$443.00 ➝ $455.00
5/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$120.00 ➝ $125.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$16.75B9.17$3.68 per share28.20$14.93 per share6.95
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
$280.21MN/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B22.57$7.96 per share66.11$46.41 per share11.33
Stryker Corporation stock logo
SYK
Stryker
$22.60B6.67$15.19 per share25.99$54.13 per share7.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$1.85B$1.3775.7632.132.6811.58%18.67%10.38%7/23/2025 (Estimated)
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8277.1368.945.6028.41%14.43%12.81%7/22/2025 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$2.99B$7.4053.3326.612.9612.31%23.74%11.25%7/31/2025 (Estimated)

Latest SYK, CSQ, ISRG, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Stryker Corporation stock logo
SYK
Stryker
$3.06N/AN/AN/A$5.92 billionN/A
7/23/2025Q2 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.72N/AN/AN/A$4.89 billionN/A
7/22/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
5/1/2025Q1 2025
Stryker Corporation stock logo
SYK
Stryker
$2.73$2.84+$0.11$1.69$5.68 billion$5.87 billion
4/23/2025Q1 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.67$0.75+$0.08$0.45$4.57 billion$4.66 billion
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
$1.236.71%N/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.360.85%N/A45.41%32 Years

Latest SYK, CSQ, ISRG, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.840.88%6/30/20256/30/20257/31/2025
7/1/2025
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
Monthly$0.10256.67%7/14/20257/14/20257/21/2025
6/2/2025
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
monthly$0.10257%6/12/20256/12/20256/20/2025
5/1/2025
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
monthly$0.10257.5%5/13/20255/13/20255/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.47
1.45
0.88
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
N/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Stryker Corporation stock logo
SYK
Stryker
0.69
1.64
1.00

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Stryker Corporation stock logo
SYK
Stryker
77.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
53,0001.48 billion1.47 billionOptionable
Calamos Strategic Total Return Fund stock logo
CSQ
Calamos Strategic Total Return Fund
N/AN/AN/ANot Optionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Stryker Corporation stock logo
SYK
Stryker
53,000381.69 million359.17 millionOptionable

Recent News About These Companies

Evercore ISI Increases Stryker (NYSE:SYK) Price Target to $415.00
What to Expect From Stryker's Next Quarterly Earnings Report

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Boston Scientific stock logo

Boston Scientific NYSE:BSX

$103.21 -0.65 (-0.63%)
As of 10:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Calamos Strategic Total Return Fund stock logo

Calamos Strategic Total Return Fund NASDAQ:CSQ

$18.28 -0.06 (-0.31%)
As of 10:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Calamos Strategic Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in common and preferred stocks of companies across all market capitalizations, convertible securities, and high yield corporate bonds with an average credit rating of BB as rated by S&P. The fund employs both fundamental and quantitative analysis with a combination of bottom-up and top-down security picking approaches to create its portfolio. Calamos Strategic Total Return Fund was formed on December 31, 2003 and is domiciled in the United States.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$516.98 -9.07 (-1.72%)
As of 10:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stryker stock logo

Stryker NYSE:SYK

$389.82 -4.95 (-1.25%)
As of 10:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.